Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析

◆英語タイトル:Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C9014
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Straumann Holding AG (STMN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company researches, develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in tooth replacement, restoration or prevention of tooth loss. It also provides training, support and other services to dental practitioners, clinics and laboratories worldwide. The company provides products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes its products, solutions and services directly and also through a network of partners in Europe, the Middle East and Africa; North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.

Straumann Holding AG Key Recent Developments

Oct 30,2018 Straumann Group sustains strong performance, as organic revenue rises 18% both in Q3 and over the first nine months of 2018 30. Oct 2018 Media Releases
Oct 17,2018 The rationale for Straumann Switzerland s initiative to offer customers a local milling service 18. Oct 2018 Media Releases
Aug 23,2018 Peter Zihla joins Straumann’s Executive Management team as new Head of the Digital Business Unit
Aug 23,2018 Peter Zihla joins Straumann’s executive management team as new head of the digital business unit 23 aug 2018 media releases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Straumann Holding AG – Key Facts 6
Straumann Holding AG – Key Employees 7
Straumann Holding AG – Key Employee Biographies 8
Straumann Holding AG – Major Products and Services 9
Straumann Holding AG – History 12
Straumann Holding AG – Company Statement 17
Straumann Holding AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Affiliate 23
Section 2 – Company Analysis 24
Company Overview 24
Straumann Holding AG – Business Description 25
Business Segment: Implant Solutions 25
Overview 25
Performance 25
Key Stats 25
Business Segment: Other 25
Overview 25
Performance 26
Key Stats 26
Business Segment: Restorative Solutions 26
Overview 26
Performance 26
Key Stats 26
Geographical Segment: Asia Pacific (APAC) 26
Target Markets 26
Performance 26
Overview 27
Geographical Segment: Europe, Middle East & Africa (EMEA) 27
Target Markets 27
Performance 27
Overview 27
Geographical Segment: Latin America (LATAM) 27
Target Markets 27
Performance 27
Overview 27
Geographical Segment: North America (NAM) 28
Target Markets 28
Performance 28
Overview 28
Straumann Holding AG – Corporate Strategy 29
Straumann Holding AG – SWOT Analysis 30
SWOT Analysis – Overview 30
Straumann Holding AG – Strengths 30
Straumann Holding AG – Weaknesses 31
Straumann Holding AG – Opportunities 32
Straumann Holding AG – Threats 33
Straumann Holding AG – Key Competitors 34
Section 3 – Company Financial Ratios 35
Financial Ratios – Capital Market Ratios 35
Financial Ratios – Annual Ratios 36
Performance Chart 39
Financial Performance 39
Financial Ratios – Interim Ratios 40
Financial Ratios – Ratio Charts 41
Section 4 – Company’s Lifesciences Financial Deals and Alliances 42
Straumann Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Straumann Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018 43
Straumann Holding AG, Recent Deals Summary 44
Section 5 – Company’s Recent Developments 45
Oct 11, 2018: ClearCorrect and Dental Monitoring connect doctors and patients with mobile clear aligner monitoring 45
Aug 23, 2018: Peter Zihla joins Straumann’s Executive Management team as new Head of the Digital Business Unit 46
Aug 14, 2018: Straumann Group: Further acceleration as first-half organic revenue climbs 18% and underlying EBITDA margin reaches 30% 47
Apr 26, 2018: Strong Growth Continues as Straumann Posts 15% Rise in Organic Revenue in Q1 50
Feb 15, 2018: Straumann Group Revenue Exceeds CHF 1bn, Rising 21% (16% organic), while Operating Margin Expands to 26% 52
Jan 03, 2018: ClearCorrect’s Flex and Unlimited pricing now available in Canada 56
Oct 26, 2017: Straumann Group raises full-year revenue outlook as organic growth reaches 15% in first nine months 57
Sep 29, 2017: Straumann receives ‘Best Company’ prize at the 2017 European Digital Communication Awards 60
Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement 61
Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1 65
Section 6 – Appendix 68
Methodology 68
Ratio Definitions 68
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Tables
Straumann Holding AG, Key Facts 6
Straumann Holding AG, Key Employees 7
Straumann Holding AG, Key Employee Biographies 8
Straumann Holding AG, Major Products and Services 9
Straumann Holding AG, History 12
Straumann Holding AG, Subsidiaries 21
Straumann Holding AG, Affiliate 23
Straumann Holding AG, Key Competitors 34
Straumann Holding AG, Ratios based on current share price 35
Straumann Holding AG, Annual Ratios 36
Straumann Holding AG, Annual Ratios (Cont...1) 37
Straumann Holding AG, Annual Ratios (Cont...2) 38
Straumann Holding AG, Interim Ratios 40
Straumann Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Straumann Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018 43
Straumann Holding AG, Recent Deals Summary 44
Currency Codes 68
Capital Market Ratios 68
Equity Ratios 69
Profitability Ratios 69
Cost Ratios 70
Liquidity Ratios 70
Leverage Ratios 71
Efficiency Ratios 71

List of Figures
Straumann Holding AG, Performance Chart (2013 - 2017) 39
Straumann Holding AG, Ratio Charts 41
Straumann Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Straumann Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 43

★海外企業調査レポート[Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Scripps Health-製薬・医療分野:企業M&A・提携分析
    Summary Scripps Health (Scripps) is a non-profit healthcare organization, which provides healthcare services including primary care and urgent and emergency care services; preventive services and wellness screening services in San Diego County in the US. Scripps offers specialized medical care with …
  • Tenaga Nasional Berhad:企業の戦略・SWOT・財務分析
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TV Asahi Corporation (9409):企業の財務・戦略的SWOT分析
    TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Vanderbilt University Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center’s services include adult emergency services, case management, corporate health services, adult psychiat …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務情報
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Medusa Mining Ltd:企業の戦略・SWOT・財務分析
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NanoString Technologies Inc (NSTG)-製薬・医療分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • Eiger BioPharmaceuticals Inc (EIGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • OMV AG (OMV):企業の戦略的SWOT分析
    OMV AG (OMV) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Momenta Pharmaceuticals Inc (MNTA):企業の財務・戦略的SWOT分析
    Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide …
  • Hologic, Inc.:企業の戦略・SWOT・財務情報
    Hologic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hologic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Perdana Petroleum Bhd (PERDANA):石油・ガス:M&Aディール及び事業提携情報
    Summary Perdana Petroleum Bhd (Perdana Petroleum), a subsidiary of Dayang Enterprise Holdings Bhd, is an offshore marine services provider with focus on the upstream oil and gas industry. The company’s owns and operates a fleet of vessels supporting offshore activities such as exploration, developme …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Heliatek GmbH:電力:M&Aディール及び事業提携情報
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Olin Corporation:企業の戦略・SWOT・財務分析
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆